EPHB4-related capillary malformation-arteriovenous malformation

Capillary malformations appear as flat, pink, or red marks on the skin, often referred to as port-wine stains. They occur due to abnormal development of the capillaries, leading to an increased number of dilated blood vessels near the surface of the skin. Over time, these marks may darken and thicken, potentially becoming more prominent. In daily life, they can cause cosmetic concerns and may require laser therapy to reduce their appearance.

Arteriovenous malformations (AVMs) are tangles of abnormal blood vessels connecting arteries and veins, bypassing the capillary system. This occurs due to genetic mutations affecting vascular development, leading to direct artery-to-vein connections. AVMs can grow over time, increasing the risk of rupture and bleeding. They can cause pain, swelling, or neurological symptoms depending on their location, and may require surgical intervention or embolization.

Venous malformations are abnormally formed veins that can appear as soft, compressible blue masses under the skin. They result from improper vein development during embryogenesis, leading to enlarged and malformed veins. These malformations can expand with age and may cause pain or functional impairment. Treatment options include sclerotherapy or surgical removal to alleviate symptoms and improve quality of life.

Pain associated with EPHB4-related malformations can be localized to the area of the vascular anomaly. It is caused by increased blood flow and pressure within the malformed vessels, leading to discomfort or aching. Pain may worsen over time as the malformation enlarges or if complications arise. Management includes pain relief medications and addressing the underlying vascular issue through medical or surgical means.

Swelling occurs in areas where vascular malformations are present, often due to increased blood flow and pressure. The biological mechanism involves the pooling of blood in the malformed vessels, leading to tissue expansion. Over time, swelling can become more pronounced and may fluctuate with physical activity or hormonal changes. Compression garments and elevation can help manage swelling, alongside specific treatments for the malformation.

Bleeding can occur spontaneously or with minor trauma in areas affected by vascular malformations. The fragile nature of the abnormal vessels makes them prone to rupture, leading to bleeding. This risk increases as the malformation grows or if it is located in a high-pressure area. Immediate medical attention is required to control bleeding, and preventive measures include protective padding and regular monitoring.

Neurological symptoms may arise if vascular malformations are located in or near the brain or spinal cord. These symptoms occur due to pressure on neural structures or bleeding within the central nervous system. Over time, symptoms such as headaches, seizures, or motor deficits may develop. Neurological evaluation and imaging are crucial for diagnosis, and treatment may involve surgical intervention to remove or reduce the malformation.

Heart failure can develop in severe cases where large arteriovenous malformations create significant blood flow shunts. This results in increased cardiac output demand, eventually leading to cardiac overload and failure. Symptoms may progress from mild fatigue and shortness of breath to severe cardiac dysfunction. Management includes medical therapy to support heart function and addressing the underlying vascular anomaly to reduce cardiac strain.

Clinicians look for capillary malformations, arteriovenous malformations, and other vascular anomalies. A detailed family history is important to identify any hereditary patterns. Physical examination focuses on skin lesions, limb overgrowth, and potential neurological symptoms. This step helps determine the need for further diagnostic imaging and testing.

Magnetic resonance imaging (MRI) is commonly used to visualize vascular anomalies. MRI can reveal abnormal connections between arteries and veins and the extent of vascular malformations. These findings confirm the presence of arteriovenous malformations and help differentiate from other vascular disorders. Imaging also helps exclude differentials such as Sturge-Weber syndrome or Klippel-Trenaunay syndrome.

Routine blood tests may be ordered to assess overall health and rule out other conditions. Specific biomarkers are not typically sought for this condition. Abnormal results might include elevated inflammatory markers if complications arise. Laboratory results guide further genetic testing and management strategies.

Genetic testing involves sequencing the EPHB4 gene. Mutations such as missense, nonsense, or frameshift mutations are identified. These results confirm the diagnosis of EPHB4-related capillary malformation-arteriovenous malformation. Genetic findings also inform family counseling regarding inheritance patterns and recurrence risks.